Loading page...
Log inCreate account
Loading page...
This round is closed. Synced from the EU Funding & Tenders Portal on 9 November 2026.
Projects the EU funded under this call, with the organisation that led each one.
SepTechSepsis Early Prediction Technology
Led by Universitaetsklinikum Freiburg · Germany · 2026 · Official record ↗
Q-MSOTQuantitative Multispectral Optoacoustic Tomography
Led by Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit und Umwelt GmbH · Germany · 2026 · Official record ↗
ETIAETIA: Causal AI for Data-Driven Insights and Optimal Decision Making
Led by Panepistimio Kritis · Greece · 2026 · Official record ↗
ELISETEmission Lifetimes technology for sorting, Security and Traceability
Led by Sinbiosys SRL · Italy · 2026 · Official record ↗
DENOVOSSDe Novo Ossification using human engineered cartilage as cell-free biomaterial
Led by Lunds Universitet · Sweden · 2026 · Official record ↗
CLUSTRELSeizure Cluster Relief through Smart Therapeutic Management
Led by Consorzio Interuniversitario Nazionale Per la Scienza e Tecnologia Dei Materiali · Italy · 2026 · Official record ↗
TRU-STACKTransparent Resource Utilisation for Scientific and Enterprise Workloads
Led by Barcelona Supercomputing Center Centro Nacional de Supercomputacion · Spain · 2026 · Official record ↗
TITANminiaTurized sIlicon phoTonics gAs seNsor-on-chip
Led by Senseair AB · Sweden · 2026 · Official record ↗
iNSyT-ONEiNSyT ONE: Real‑time single‑particle quality control for quantum dots and nanomaterials
Led by Ludwig-Maximilians-Universitaet Muenchen · Germany · 2026 · Official record ↗
NANOCARRevolutionizing Blood Cancer Therapy: Next-Gen CAR-T Therapy with In Vivo Nanoparticle Targeting
Led by Nanocell Therapeutics B.v. · Netherlands · 2026 · Official record ↗
Based on recent winners of this scheme in other years.
Each one links to its EU funding record and the partners it works with: a starting list for building a consortium.
Scope:EIC Transition funds innovation activities that go beyond the experimental proof of principle in laboratory. It supports both the maturation and validation of your novel technology from the lab to the relevant application environments (by making use of prototyping, formulation, models, user testing or other validation tests) as well as explorations and development of a sustainable business case and business model towards commercialisation.
Your proposed activities must include further technology development on the results achieved in a previous project and follow user-centric methodologies to increase chances of the innovation’s future success in the market. EIC Transition projects should address, in a balanced way, both technology and market/business development, possibly including iterative learning processes based on early customer or user feedback. These activities should include, subject to the level of maturity of the technology, a suitable mix of technology development and validation activities to increase the maturity of the technology beyond proof of concept to viable demonstrators of the technology in the intended field of application (i.e., from TRL 4 up to Technology Readiness Level 5 to 6). The activities must in all cases address market readiness towards commercialisation and deployment (market research, value proposition, business case and business model, prospects for growth, intellectual property protection, competitor analysis etc.) and aspects of regulation, certification and standardisation (if relevant), aimed at getting both the technology and the business idea investment ready.
More information can be found in the EIC WP 2025.
1. Admissibility Conditions: Proposal page limit and layout
Your proposal must build on results (at least experimental proof of concept TRL 3, ideally technology validated in the lab TRL 4) already achieved within an eligible project. You can apply for EIC Transition either as:
- A single legal entity established in a Member State or an Associated Country (‘mono-beneficiary’)
- A small consortium of two independent legal entities from two different Member States or Associated Countries or
- A consortium of minimum three and maximum five independent legal entities (‘multi-beneficiary’) following standard rules i.e. must include at least one legal entity established in a Member State and at least two other independent legal entities, each established in different Member States or Associated Countries.
The legal entities may for example be a start-up, an SME or research performing organisation (university, research or technology organisation, including teams, individual Principal Investigators and inventors in such institutions who intend to form a spinout company).
The standard admissibility and eligibility conditions as well as the eligibility of applicants from third countries are detailed in Annex 2 of the EIC Work Programme 2025.
Proposal page limits and layout:
Described in Part B of the Application Form available in the Submission System.
Sections 1 to 3 and the cover page (that includes the information about the related project on which the current EIC Transition proposal is built on) of the part B of your proposal, corresponding respectively to the evaluation criteria Excellence, Impact, and Quality and Efficiency of the Implementation, must consist of a maximum of 22 A4 pages. Excess pages will be automatically made invisible, and will not be taken into consideration by the evaluators. Please also consult Annex 2 of the EIC Work Programme 2025.
2. Eligible Countries
described in Annex B of the Work Programme General Annexes.
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
The eligibility of applicants from third countries is explained in Annex 2 of the EIC Work Programme 2024.
3. Other Eligible Conditions
The EIC Transition is restricted to proposals based on results generated by the eligible projects described in the EIC Work Programme 2025.
4. Financial and operational capacity and exclusion
Described in Annex 2 of the EIC Work Programme 2025.
5a. Evaluation and award: Award criteria, scoring and thresholds
Described in section III of the EIC Work Programme 2025.
5b. Evaluation and award: Submission and evaluation processes
Described in section III of the EIC Work Programme 2025 and the Online Manual.
5c. Evaluation and award: Indicative timeline for evaluation and grant agreement
Described in section III of the EIC Work Programme 2025.
6. Legal and financial set-up of the grants
Please refer to the Model Grant Agreement (MGA) used for EIC actions under Horizon Europe.
described in the EIC Work Programme 2025
Call documents
EIC Work Programme 2025
Frequently Asked Questions (FAQs)
Standard application form (will be made available in the submission workflow). Do not use previous years' template versions as this may lead to incomplete applications.
Standard evaluation form (HE EIC TRANSITION)
Model Grant Agreements (MGA)
Lump Sum MGA
Call-specific instructions
Detailed budget table (HE LS)
Information on clinical studies (HE)
Guidance: "Lump sums - what do I need to know?"
Additional documents:
HE Programme Guide
HE Framework Programme 2021/695 
HE Specific Programme Decision 2021/764 
EU Financial Regulation 2018/1046
Rules for Legal Entity Validation, LEAR Appointment and Financial Capacity Assessment 
EU Grants AGA — Annotated Model Grant Agreement 
Funding & Tenders Portal Online Manual 
Funding & Tenders Portal Terms and Conditions 
Funding & Tenders Portal Privacy Statement
Confirm the current call documents and submission conditions with the funding authority.
View on EU portal ↗Source: EU Funding & Tenders Portal · synced 2026-11-09
A free account keeps your shortlist and sends deadline reminders. The EUACC connector brings this call, its FAQs, past winners and similar calls into Claude or ChatGPT, so you can check fit and draft with sources.